illuminating altered metabolic signaling in cancer

talks

 

Presentations and Talks

 
 

NIH Redox Biology SIG Seminar

What are the targets of chemotherapy-generated reactive oxygen species (ROS)? How are these ROS sensed in the cell and what effect do they have on different pathways? Click to watch this seminar given by Liron Bar-Peled, PhD.

Systematic Targeting of Protein Complexes

with Molecular COUPLrs

This a summary on our work on COUPLrs, molecular glues with dual warheads that can capture protein complexes. Click the video to hear the presentation given by Stefan Harry, PhD.

Identification of Druggable and Redox

Vulnerabilities in Cancer

How can we understand druggable redox vulnerabilities in cancer from a proteomics perspective? Click to learn more about our discoveries on the effects of oxidation on Complex I and its connection to cancer metastasis. Presentation given by Liron Bar-Peled, PhD.

Mapping the Druggable Proteome

What does “undruggable” mean now in cancer drug discovery? How can we turn the chemical proteomics platform into a pipeline to target druggable proteins? What role could AI play in the future? In this interview, Dr. Liron Bar-Peled discusses these topics with Chief Operating Officer of Deerfield Discovery and Development (3DC), Dr. Nadim Shohdy.